Mirnext

company

About

Mirnext focuses on the discovery, validation, and commercialization of miRNAs as novel biomarkers for cardiovascular disease.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Industries
Biotechnology,Genetics,Health Care,Lifestyle,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Mirnext, a biomedical company, focuses on the discovery, validation, and commercialization of miRNAs as novel biomarkers for cardiovascular disease. Its multiple circulating miRNAs act as informative markers for the diagnosis of heart failure, coronary artery disease, and myocardial infarction, as well as used to predict cardiovascular risk, such as mortality and hospitalization.

Mirnext also develops multi-marker tests to improve diagnostic routine and clinical management of patients entering the clinic with symptoms of heart failure or coronary artery disease. It has its headquarters in Amsterdam in the Netherlands.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Mirnext has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 1, 2012 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2012 Series Unknown 1 Limburg Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Mirnext is funded by 1 investors. Limburg Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Limburg Ventures Yes Series Unknown